Brief ReportClinical Implications of Variant ALK FISH Rearrangement Patterns
Key Words
Cited by (0)
Sources of supported are Wong Family Fellowship in Translational Oncology, Harold and Gail Kirstein Lung Cancer Research Fund, 1K23CA157631 (NCI), and R01CA136851. LMS retains board membership with Genentech. MN receives consulting fees from Bristol-Myers Squibb. PAJ has received consulting fees from Pfizer and Chugai Pharmaceuticals. GRO has received consulting fees from AstraZeneca, Sanofi, Clovis, Novartis, Genentech, Boehringer-Ingelheim and honoraria from Chugai.
Disclosure: LMS retains board membership with Genentech. MN receives consulting fees from Bristol-Myers Squibb. PAJ has received consulting fees from Pfizer and Chugai Pharmaceuticals. GRO has received consulting fees from AstraZeneca, Sanofi, Clovis, Novartis, Genentech, Boehringer-Ingelheim and honoraria from Chugai..